Elicio Therapeutics (9HA.F) Q2 2025 Earnings

13MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.32
-1.07
-0.83
-0.58

Details

Expected EPS
-0.7417129
Actual EPS
-0.7774581
Surprise EPS
-0.04
Surprise Percent
+4.82%

Description

Elicio Therapeutics (9HA.F) has reported earnings of -0.7774581 per share for Q2 2025.

0 Comments

Share your thoughts